ClinicalTrials.Veeva

Menu

Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study (DYNA-LCS P)

P

Poitiers University Hospital

Status

Completed

Conditions

Healthy Subjects or Volunteers
Cerebrospinal Fluid

Treatments

Other: MRI Contrast

Study type

Interventional

Funder types

Other

Identifiers

NCT06743347
2024-A02411-46

Details and patient eligibility

About

This research will enhance our knowledge and understanding of Cerebrospinal Fluid (CSF) circulation around the Central Nervous System (CNS) (brain and spinal cord).

The main objective is to obtain flow velocities using Phase Contrast (PC) MRI over the entire subarachnoid space (SAS). This will enable us to develop and validate a numerical model of the SAS.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years at the time of agreement
  • Free subject, without guardianship or curatorship or subordination
  • Patients benefiting from a Social Security scheme or benefiting from it through a third party
  • Informed consent signed by the patient after clear and complete information about the study

Exclusion criteria

  • 3T MRI contraindications (pacemaker, cochlear implant, metallic splinter, etc)
  • History of neurological pathology
  • Previous operations involving the central nervous system (spinal surgery, neurological surgery, etc.)
  • Current pathology or treatment that may interfere with the CSF or subarachnoid spaces (CSF dysregulation, disc herniation, hydrocephalus, Chiari malformation, etc.)
  • Concurrent participation in another clinical research study
  • Persons not covered by Social Security or not covered by Social Security through a third party
  • Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, adults under legal protection
  • Pregnant or breastfeeding women, women of childbearing age who do not have effective contraception (hormonal/mechanical: oral, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy)

Exclusion criteria during the study:

- Discovery of a contraindication to 3T MRI (pacemaker, cochlear implant, metallic splinter, etc)

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Phase Contrast MRI
Experimental group
Treatment:
Other: MRI Contrast

Trial contacts and locations

1

Loading...

Central trial contact

Philippe Rigoard, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems